FDA Botanical Review Team To Implement Herbals Guidance, MaPP

The newly formed Botanical Review Team in FDA's Office of New Drugs is intended to "consolidate OND's scientific and regulatory expertise in botanical products," according to a Feb. 20 agency announcement

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet